ESP-31015
ESP-31015 (ETC-1001) is an orally active and non-fibrate based PPARα agonists. ESP-31015 demonstrates significant lipid-regulating effects in the obese Zucker rat model. ESP-31015 can be used in cardiovascular disease research.
For research use only. We do not sell to patients.
- CAS No.: 413624-55-2
- Formula: C17H34O3
- Molecular Weight:286.45
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
PPARα |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Hepatocyte | IC50 |
1.5 μM
Compound: 39
|
Inhibition of lipid synthesis in primary rat hepatocytes by incorporation radiolabeled acetate into cellular lipids
Inhibition of lipid synthesis in primary rat hepatocytes by incorporation radiolabeled acetate into cellular lipids
|
[PMID: 16392818] |
| Hepatocyte | IC50 |
4 μM
Compound: 14c
|
Concentration required for inhibition of lipid synthesis in primary cultures of rat hepatocytes
Concentration required for inhibition of lipid synthesis in primary cultures of rat hepatocytes
|
[PMID: 15537362] |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female obese Zucker fatty rats model[1]
-
Dosage:100 mg/kg
-
Administration:Oral administration (p.o.), once daily for 2 weeks
-
Result:Showed a 34.6% increase in serum HDL-cholesterol and a 71% reduction in serum triglycerides.
Chemical Information
-
CAS No. 413624-55-2
-
Molecular Weight 286.45
-
Formula C17H34O3
-
SMILES
OCC(C)(C)CCCCC(CCCCC(C)(C)CO)=O
-
Synonyms
ETC-1001
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)